SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028026
Filing Date
2018-11-07
Accepted
2018-11-07 16:12:58
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20180930.htm 10-Q 1394668
2 EX-3.1 crsp-ex31_405.htm EX-3.1 446171
3 EX-10.1 crsp-ex101_445.htm EX-10.1 1158184
4 EX-31.1 crsp-ex311_8.htm EX-31.1 19673
5 EX-31.2 crsp-ex312_6.htm EX-31.2 19740
6 EX-32.1 crsp-ex321_7.htm EX-32.1 7763
7 GRAPHIC gleawceockkv000001.jpg GRAPHIC 9264
  Complete submission text file 0001564590-18-028026.txt   8903571

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT crsp-20180930.xml EX-101.INS 1816696
9 XBRL TAXONOMY EXTENSION SCHEMA crsp-20180930.xsd EX-101.SCH 53891
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20180930_cal.xml EX-101.CAL 36533
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20180930_def.xml EX-101.DEF 228390
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20180930_lab.xml EX-101.LAB 408252
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20180930_pre.xml EX-101.PRE 338906
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 181166478
SIC: 2836 Biological Products, (No Diagnostic Substances)